Forest announces availability of Daliresp

NEW YORK — A drug for chronic obstructive pulmonary disease made by Forest Labs will be available by the middle of this month, Forest said Thursday.

Daliresp (roflumilast) recently received approval from the Food and Drug Administration as a treatment to reduce the risk of exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

Forest said Daliresp, a daily oral tablet, is the first and only approved drug in its class, known as selective phosphodiesterase-4 inhibitors.

NEW YORK and WATERTOWN, Mass. — The Juvenile Diabetes Research Foundation and Selecta Biosciences have established a research collaboration to develop vaccines for Type 1 diabetes, also known as juvenile diabetes.

Through the collaboration, JDRF will provide "milestone-based financial support and expertise" to Selecta, which ultimately would apply its vaccine technology to create a vaccine that would halt or prevent the autoimmune response that causes Type 1 diabetes.

The research collaboration between JDRF and Selecta is part of JDRF’s Industry Discovery and Development Partnership program, which launched in 2004.

"Through partnerships like this, JDRF is helping to speed the development of products from the lab to the marketplace, to make sure breakthroughs in science are able to reach the people they are meant to help," JDRF SVP strategic alliances Karin Hehenberger said. "Pooling the resources and strengths of both JDRF and Selecta allows us to work together to advance research that could help many people who have or are at risk for Type 1 diabetes, and we will be more effective in making these innovative products available to them."

"Through its many hospitals and neighborhood health centers, OhioHealth has a strong primary care presence in the Columbus area and an outstanding record for clinical quality," said Andrew Sussman, MinuteClinic president and SVP/associate chief medical officer at CVS Caremark. "As we have experienced elsewhere in Ohio and in other communities in the [United States], strategic clinical affiliations between MinuteClinic and major health systems — such as OhioHealth — enhance our ability to extend high-quality medical services to patients in convenient retail locations near where they live and work."

Under the agreement, physicians affiliated with OhioHealth will serve as medical directors for MinuteClinic locations in central Ohio. In addition, MinuteClinic and OhioHealth will collaborate on patient education and disease management initiatives and will inform patients of the services provided by each organization. OhioHealth will accept patients who need a level of care that is not provided at MinuteClinic.

MinuteClinic and OhioHealth also will begin integrating their electronic medical record systems to streamline communication around all aspects of each individual’s care.

"We view this as an extension of the continuum of care we offer in our hospitals, urgent care centers, primary care offices, emergency departments and more than 20 community-based outpatient centers," said Bob Gilbert, senior operations officer at OhioHealth Neighborhood Care. "This affiliation enables OhioHealth to increase the community’s access to our high-quality care and trusted team of medical professionals — providing another way to connect patients to our services."

With patient consent, MinuteClinic will share medical history and visit summaries with other OhioHealth and MinuteClinic locations in the region. In the meantime, MinuteClinic stated that it will continue its standard practice of sending visit summaries via fax or mail to the patient’s primary care physician, typically within 24 hours. This reporting is not always possible, however, as not all MinuteClinic patients have a primary care physician.

"More than 50% of patients seen at MinuteClinic locations in Columbus do not have an established primary care relationship," OhioHealth SVP and chief medical officer Bruce Vanderhoff said. "Together, OhioHealth and MinuteClinic are committed to helping these patients re-engage with traditional primary care physicians."

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry